Coagulants Market Growth: Trends and Insights for 2024-2030
The global coagulants market size is expected to reach USD 17.01 billion in 2030 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. The market in healthcare is primarily driven by the increasing prevalence of bleeding disorders and chronic diseases that require blood clotting factors for treatment. Conditions like hemophilia, von Willebrand disease, and thrombophilia necessitate the use of coagulants to manage and control them effectively. The rising incidence of these disorders globally is propelling the demand for this market. The convenient treatment options and technological advancements drive growth by expanding the range of available therapies and enhancing patient adherence to treatment regimens. For instance, In April 2024, Avenacy launched its FDA-approved Desmopressin Acetate Injection in the U.S., serving as a generic alternative to DDAVP Injection. This medication is aimed at treating central diabetes insipidus, hemophilia A, and Type I von Willebrands disease....